AngioDynamics, Inc. has announced FDA 510(k) clearance for Oncobionic, Inc. to market Irreversible Electroporation (IRE) ...
Possis Medical, Inc. has received clearance from the FDA to market its AngioJet Xpeedior catheter to remove blood clots (thrombus) from upper- and lower-extremity peripheral veins. Used with the company’s AngioJet System, Xpeedior is the only device cleared for thrombectomy in peripheral veins.
The Third International Conference on Cell Therapy for Cardiovascular Diseases will convene Jan 17 to 19, at The New York Academy of Medicine in New York, NY. The three-day program is dedicated to the evolving field of cell-based therapies for cardiac repair and regeneration.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
GE Healthcare has launched its new LightSpeed VCT XT, the industry’s first CT scanner that maintains outstanding image ...
An implantable technology to control high blood pressure in patients not responding to available medicines has ...
The FDA has cleared Toshiba's new EXCELART Vantage Atlas 1.5T MRI system, which the company showcased this week during ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
An innovative lead insulation material for cardiac leads used with pacemakers and ICDs is now FDA approved and available ...
November 2006 - Toshiba America Medical Systems, Inc. has announced a new partnership with CVCTA Education and San ...
In its third quarter financial report, San Diego-based Cytori said it has moved significantly closer to initiating its cardiovascular clinical trials," said Christopher J. Calhoun, chief executive officer of Cytori Therapeutics. The company is developing adipose stem cells in cardiovascular disease and for use in reconstructive surgery.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Houston based ThromboVision, Inc. has won the first annual Michael E. DeBakey Life Science Award, which carries a $50,000 cash prize to assist in propelling the company's technology toward commercial success.
The stent market will have a distinctly different look after Johnson & Johnson completes its acquisition of Conor ...
A German physician reports that people who have implanted pacemakers or defibrillators are not in danger of their ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Siemens Medical Solutions’ ACUSON Antares ultrasound system, premium edition, features shared service cardiology ...
Photos of medical images produced from a new 3-D volume rendering software have the appearance of something from a “Star ...
Cordis Corp. has received approval from the FDA to market its PRECISE Nitinol Stent and ANGIOGUARD Emboli Capture guide ...